In a recent interview with the Investing News Network, Naturally Splendid (TSXV:NSP) discussed its revolutionary omega extraction technology and its $30-million processing facility in Saskatchewan.
Connect with Naturally Splendid (TSXV:NSP) to receive an investor presentation.
Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.
For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.
<p>On behalf of the Board of Directors<b><br/><a href="https://investingnews.com/company-profiles/matica-enterprises-low-cost-medical-cannabis-producer-quebec/">Matica Enterprises</a> INC.</b><u><br/>Boris Ziger</u><br/>Boris Ziger, CEO & Chairman</p>
<p>The Company’s public filings are available for review at <a href="https://www.newsfilecorp.com/redirect/Ww1jfBabv" rel="noopener noreferrer" target="_blank">www.sedar.com</a> and <a href="https://www.newsfilecorp.com/redirect/qJnguQRwv" rel="noopener noreferrer" target="_blank">www.thecse.com</a>.</p>
<p>For further information, please contact Boris Ziger, at:<b><br/>Telephone: 416-304-9935<br/>E-mail: </b><a href="mailto:info@maticaenterprises.com" rel="noopener noreferrer" target="_blank"><b>info@maticaenterprises.com</b></a><b><br/>Website: </b><a href="https://investingnews.com/company-profiles/matica-enterprises-low-cost-medical-cannabis-producer-quebec/" rel="noopener noreferrer" target="_blank"><b>www.maticaenterprises.com</b></a> , <a href="https://www.newsfilecorp.com/redirect/Kv15t7Kgr" rel="noopener noreferrer" target="_blank"><b>www.maticammj.com</b></a></p>
<p><i>Disclaimer for Forward-Looking Information</i></p>
<p><i>Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at <a href="https://www.newsfilecorp.com/redirect/EDK3S0Ya8" rel="noopener noreferrer" target="_blank">www.sedar.com</a>.</i></p>
<p><i>This news release contains statements about the Company’s information that may be made available on the S&P Capital IQ Corporation Records Listing Program and the business of Matica that are forward-looking in nature and as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.</i></p>
<p><i>Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.</i></p>
<p id="corporateNewsLogoContainer"><img alt="Corporate Logo" class="lazy" data-src="https://orders.newsfilecorp.com/files/3200/72664_7539e7fbf490db33_logo.jpg" data-srcset="" id="corporateNewsLogo" src="https://orders.newsfilecorp.com/files/3200/72664_7539e7fbf490db33_logo.jpg" srcset=""/></p>
<p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://www.newsfilecorp.com/redirect/xLn0IJ8z8" rel="noopener noreferrer" target="_blank">https://www.newsfilecorp.com/release/72664</a></p>
<p><img alt="" class="lazy" data-src="https://www.newsfilecorp.com/newsinfo/72664/310" data-srcset="" src="https://www.newsfilecorp.com/newsinfo/72664/310" srcset=""/></p>
</div>
<p>News Provided by Newsfile via QuoteMedia</p>
<p></p><div class="stock-information sidebar-block">
<div class="title">Request an Investor Kit: <h3>Matica Enterprises</h3></div>
<form action="https://investingnews.com" id="subscribe_per_category" method="POST">
<div class="form-column left">
<input name="profiles_only" type="hidden" value="yes"/><input name="subscription_form" type="hidden" value="yes"/><input name="subscribe_company_profile_form" type="hidden" value="1"/><input name="source" type="hidden" value="https://investingnews.com/news/cannabis-investing/matica-board-grants-stock-options/"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="form_name" type="hidden" value="subscribe_cprofile_use_posts"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="cprofiles[]" type="hidden" value="Tzo4OiJzdGRDbGFzcyI6NDp7czoyOiJpZCI7czozNjoiYzk1ZjVmMzAtYzdjNy01ZmMwLTg0NWQtNWJlZGEyMGIzMDc3IjtzOjQ6Im5hbWUiO3M6MTg6Ik1hdGljYSBFbnRlcnByaXNlcyI7czo0OiJ3cGlkIjtzOjk6IjEwMTQ3MTk3MSI7czozOiJ1cmwiO3M6MDoiIjt9"/><input class="form-control" id="FirstName" name="first_name" placeholder="First Name" required="" type="text" value=""/><input class="form-control" id="LastName" name="last_name" placeholder="Last Name" required="" type="text" value=""/><input class="form-control" id="email" name="email" placeholder="Email" required="" type="email" value=""/><input class="form-control" id="phone" name="user_phone" pattern="[\+\s0-9]{3,15}" placeholder="Phone" title="Telephone number. Only digits and space signs are allowed" type="tel" value=""/></div>
<input class="g-recaptcha-response" id="g-recaptcha-response_3779" name="g-recaptcha-response" type="hidden"/><input class="value_recaptcha" name="action" type="hidden" value="validate_captcha_3779"/><div class="form-column right">
<div class="extra-input">
<input id="AccreditedInvestor" name="accredited_investor" type="checkbox"/><label class="checkbox-label" for="AccreditedInvestor">
Include me in the <b>Accredited Investor</b> email list
<span class="help">
<i aria-hidden="true" class="fa fa-question-circle"></i>
<div class="help-box bigger">
Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above.
</div>
</span>
</label>
</div>
<div class="more">
<input class="btn btn-primary" type="submit" value="Get More information"/></div>
<p class="legend">By completing this form, you are giving consent to receive communication from Matica Enterprises using the contact information you provide. And remember you can unsubscribe at any time.</p>
</div>
</form>
</div>
Keep reading...
Show less
The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities
– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .
<p> Today <span> Arizona </span> became the 11th state to commence adult-use cannabis sales; the announcement comes after Proposition 207, the Smart and Safe Arizona Act (SSAA), passed by a majority vote last November. Under the new law, adults 21 years of age or older may use, possess, or transfer up to one ounce of cannabis. Adult-use purchases are subject to a 16% excise tax and the potential tax revenue, estimated to reach <span> $166 million </span> , will fund community colleges, infrastructure, public safety and public health programs. The SSAA also allows courts to vacate and expunge certain cannabis arrests, charges, adjudications, convictions, and sentences. </p>
<p> Curaleaf is one of the first operators in the state to begin serving adult-use customers, and will do so effectively immediately at its eight existing dispensaries, with a ninth retail location opening in the coming months. In anticipation of customer demand, the Company expects to increase its current team of 420 employees by 120 new hires in the immediate future. Curaleaf is actively operating dispensaries in nine medical-only states and eleven states that permit medical cannabis and have allowed adult-use cannabis. </p>
<p> “We are delighted to have the opportunity to finally open our doors to all adult-use consumers and medical patients throughout the state after nearly two million residents voted in favor of Proposition 207 last year,” said <span> Steve Cottrell </span> , President of Curaleaf Arizona. “Curaleaf has been an advocate for patient health and wellness in this state for over three years, and we remain committed to serving our customers, both new and existing, during this momentous occasion.” </p>
<p> “This announcement marks an important step forward in <span> Arizona </span> , as consumers can now legally purchase adult-use cannabis for their various health and wellness needs,” said <span> Joe Bayern </span> , CEO of Curaleaf. “In anticipation of this milestone, Curaleaf has expanded its capacity across the market to meet expected widespread demand. Not only will adult-use cannabis generate important tax revenues that will contribute to <span> Arizona’s </span> economic recovery from COVID-19, it will also create local jobs and provide necessary funding for <span> Arizona’s </span> community and infrastructure needs.” </p>
<p> For more information about Curaleaf’s <span> Arizona </span> retail locations, please visit <u> <a href="https://c212.net/c/link/?t=0&l=en&o=3044295-1&h=1275330437&u=https%3A%2F%2Fcuraleaf.com%2Flocations%2F&a=https%3A%2F%2Fcuraleaf.com%2Flocations%2F" rel="nofollow noopener noreferrer" target="_blank"> https://curaleaf.com/locations/ </a> </u> . </p>
<p> <b> About Curaleaf Holdings, Inc. <br/></b> Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading U.S. provider of consumer products in cannabis, with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a vertically integrated, high-growth cannabis operator known for quality, expertise and reliability, the company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf currently operates in 23 states with 96 dispensaries, 23 cultivation sites and over 30 processing sites, and employs over 3,800 team members across <span> the United States </span> . Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information please visit <a href="https://c212.net/c/link/?t=0&l=en&o=3044295-1&h=4226357728&u=http%3A%2F%2Fwww.curaleaf.com%2F&a=www.curaleaf.com" rel="nofollow noopener noreferrer" target="_blank"> www.curaleaf.com </a> . </p>
<p> <b> INVESTOR CONTACT <br/></b> Curaleaf Holdings, Inc. <br/><span> Dan Foley </span> , VP, Finance and Investor Relations <br/><a href="mailto:IR@curaleaf.com" rel="nofollow noopener noreferrer" target="_blank"> IR@curaleaf.com </a> <br/> 781-451-0145 </p>
<p> <b> MEDIA CONTACT <br/></b> Curaleaf Holdings, Inc. <br/><span> Tracy Brady </span> , VP Corporate Communications <br/><a href="mailto:media@curaleaf.com" rel="nofollow noopener noreferrer" target="_blank"> media@curaleaf.com </a> <br/> 781-486-1037 </p>
<p> <b> FORWARD LOOKING STATEMENTS <br/></b> This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward looking statements and information may be identified by the use of forward-looking terminology such as “plans”, “expects” or, “proposed”, “is expected”, “intends”, “anticipates”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under “Risk Factors and Uncertainties” in the Company’s latest annual information form filed <span> September 25, 2020 </span> , which is available under the Company’s SEDAR profile at <a href="http://www.sedar.com" rel="nofollow noopener noreferrer" target="_blank"> http://www.sedar.com </a> , and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release. </p>
<p id="PURL"> <img alt="Cision" class="lazy" data-src="https://c212.net/c/img/favicon.png?sn=NE55930&sd=2021-01-22" data-srcset="" height="12" src="https://c212.net/c/img/favicon.png?sn=NE55930&sd=2021-01-22" srcset="" title="Cision" width="12"/> View original content: <a href="http://www.prnewswire.com/news-releases/curaleaf-launches-adult-use-operations-in-arizona-301213398.html" id="PRNURL" rel="nofollow noopener noreferrer" target="_blank"> http://www.prnewswire.com/news-releases/curaleaf-launches-adult-use-operations-in-arizona-301213398.html </a> </p>
<p> SOURCE Curaleaf Holdings, Inc. </p>
</div>
<p> <img alt="" class="lazy" data-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NE55930&Transmission_Id=202101221448PR_NEWS_USPR_____NE55930&DateId=20210122" data-srcset="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=NE55930&Transmission_Id=202101221448PR_NEWS_USPR_____NE55930&DateId=20210122" srcset=""/></p></div>
<p>News Provided by PR Newswire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
Harvest Health & Recreation Inc. Registers First Recreational Cannabis Sales in Arizona
January 22 | 2021
Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .
</div>
<p> “We are thrilled to record the first sale and begin offering access to regulated and legal cannabis products to recreational customers on this historic day in <span> Arizona </span> ,” said Chief Executive Officer <span> Steve White </span> . “Initial sales commenced only 80 days from the election and 54 days after the election was certified, representing by far the fastest launch to date in history. The Department of Health Services did an incredible job expediting this process, helping operators like Harvest sell recreationally to Arizonans 21 years of age and older. We look forward to serving both medical patients and recreational customers across the state at our retail stores.” </p>
<p> Harvest currently operates 15 dispensaries in <span> Avondale </span> , <span> Casa Grande </span> , <span> Chandler </span> , <span> Cottonwood </span> , <span> Glendale </span> , <span> Guadalupe </span> , Lake Havasu, <span> Mesa </span> , <span> Peoria </span> , <span> Phoenix </span> , <span> Scottsdale </span> , <span> Tempe </span> , and <span> Tucson </span> supported by cultivation facilities in <span> Camp Verde </span> , <span> El Mirage </span> , <span> Phoenix </span> , and <span> Willcox </span> and processing facilities in <span> Flagstaff </span> and <span> Phoenix </span> . Additional information and updates on the launch of recreational cannabis sales at Harvest’s <span> Arizona </span> locations can be found at: <a href="https://c212.net/c/link/?t=0&l=en&o=3043753-1&h=313653862&u=https%3A%2F%2Fwww.harvesthoc.com%2Frecreational-dispensary%2F&a=https%3A%2F%2Fwww.harvesthoc.com%2Frecreational-dispensary%2F" rel="nofollow noopener noreferrer" target="_blank"> https://www.harvesthoc.com/recreational-dispensary/ </a> . </p>
<p> <b> <i> About Harvest Health & Recreation Inc. <br/></i> </b> <i> Headquartered in Tempe, <span> Arizona </span> , Harvest Health & Recreation Inc. is a vertically integrated cannabis company and multi-state operator. Since 2011, Harvest has been committed to expanding its retail and wholesale presence throughout the U.S., acquiring, manufacturing, and selling cannabis products for patients and consumers in addition to providing services to retail dispensaries. Through organic license wins, service agreements, and targeted acquisitions, Harvest has assembled an operational footprint spanning multiple states in the U.S. Harvest’s mission is to improve lives through the goodness of cannabis. We hope you’ll join us on our journey: </i> <i> <u> <a href="https://c212.net/c/link/?t=0&l=en&o=3043753-1&h=4135044939&u=https%3A%2F%2Fharvesthoc.com%2F&a=https%3A%2F%2Fharvesthoc.com" rel="nofollow noopener noreferrer" target="_blank"> https://harvesthoc.com </a> </u> </i> <i> </i> </p>
<p> <b> Facebook: </b> <u> <a href="https://c212.net/c/link/?t=0&l=en&o=3043753-1&h=780937762&u=https%3A%2F%2Fwww.facebook.com%2FHarvestHOC&a=%40HarvestHOC" rel="nofollow noopener noreferrer" target="_blank"> @HarvestHOC <br/></a> </u> <b> Instagram: </b> <u> <a href="https://c212.net/c/link/?t=0&l=en&o=3043753-1&h=4198927555&u=https%3A%2F%2Fwww.instagram.com%2Fharvesthoc%2F&a=%40HarvestHOC" rel="nofollow noopener noreferrer" target="_blank"> @HarvestHOC </a> </u> <br/><b> Twitter: </b> <u> <a href="https://c212.net/c/link/?t=0&l=en&o=3043753-1&h=4168487360&u=https%3A%2F%2Ftwitter.com%2Fharvesthoc&a=%40HarvestHOC" rel="nofollow noopener noreferrer" target="_blank"> @HarvestHOC </a> </u> </p>
<p> <b> Forward-looking Statements <br/></b> <i> This press release may contain “forward-looking statements” regarding Harvest’s business strategies or prospects, which may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions. Such statements include, but are not limited to, the following: our growth potential in the <span> Arizona </span> recreational cannabis market and the sustainability of such growth; our ability to successfully and timely execute our business and operational plans in <span> Arizona </span> ; the development of favorable federal and state cannabis regulatory frameworks in <span> the United States </span> applicable to multi-state cannabis operators, including a delay in, or a failure to, federally decriminalize cannabis in <span> the United States </span> ; and adverse changes in the public perception of cannabis. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including assumptions in respect of current and future market conditions. Actual results, performance or achievement could differ materially from that expressed in, or implied. </i> </p>
<div id="DivAssetPlaceHolder2"> </div>
<p id="PURL"> <img alt="Cision" class="lazy" data-src="https://c212.net/c/img/favicon.png?sn=LA55373&sd=2021-01-22" data-srcset="" height="12" src="https://c212.net/c/img/favicon.png?sn=LA55373&sd=2021-01-22" srcset="" title="Cision" width="12"/> View original content to download multimedia: <a href="http://www.prnewswire.com/news-releases/harvest-health--recreation-inc-registers-first-recreational-cannabis-sales-in-arizona-301213389.html" id="PRNURL" rel="nofollow noopener noreferrer" target="_blank"> http://www.prnewswire.com/news-releases/harvest-health–recreation-inc-registers-first-recreational-cannabis-sales-in-arizona-301213389.html </a> </p>
<p> SOURCE Harvest Health & Recreation Inc. </p>
</div>
<p> <img alt="" class="lazy" data-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA55373&Transmission_Id=202101221416PR_NEWS_USPR_____LA55373&DateId=20210122" data-srcset="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA55373&Transmission_Id=202101221416PR_NEWS_USPR_____LA55373&DateId=20210122" srcset=""/></p></div>
<p>News Provided by PR Newswire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.
</div>
<p> HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 states of <span> the United States </span> and select international locations. The Company’s diverse product portfolio comprises 46 SKUs including tinctures, proprietary FDA Drug Listed Over The Counter (OTC) Topicals, Doctor/Practitioner Lines and more. <u> <a href="https://investingnews.com/company-profiles/hempfusion-wellness/" rel="nofollow noopener noreferrer" target="_blank"> https://www.hempfusion.com/ </a> </u> </p>
<p> <b> <i> For Market Openings: </i> </b> <i> Media may pick up a feed from the TOC (television operations centre) for all market open ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is produced at the TMX Broadcast Centre and sent live to the TOC. To pick up the feed via the Dejero network, please contact <a href="mailto:avservices@tmx.com" rel="nofollow noopener noreferrer" target="_blank"> avservices@tmx.com </a> . The client feature video will begin playing on the TMX media wall at approximately <span> 9:27 a.m. ET </span> and the markets will open with the sound of a siren at <span> 9:30 a.m. ET </span> . </i> </p>
<p> <b> Date: </b> <b> <span> Friday, January 22, 2021 </span> <br/> Time: <span> 9:00am – 9:30am </span> <br/></b> <b> Place: Virtually Broadcast </b> </p>
<div id="DivAssetPlaceHolder2"> </div>
<p> SOURCE TMX Group Limited </p>
<p> <img alt="" class="lazy" data-src="https://rt.newswire.ca/rt.gif?NewsItemId=C8250&Transmission_Id=202101221141CANADANWCANADAPR_C8250&DateId=20210122" data-srcset="" src="https://rt.newswire.ca/rt.gif?NewsItemId=C8250&Transmission_Id=202101221141CANADANWCANADAPR_C8250&DateId=20210122" srcset=""/></p>
<p> <img alt="Cision" class="lazy" data-src="https://c212.net/c/img/favicon.png?sn=C8250&sd=2021-01-22" data-srcset="" height="12" src="https://c212.net/c/img/favicon.png?sn=C8250&sd=2021-01-22" srcset="" title="Cision" width="12"/> View original content to download multimedia: <a href="http://www.newswire.ca/en/releases/archive/January2021/22/c8250.html" rel="noopener noreferrer" target="_blank"> http://www.newswire.ca/en/releases/archive/January2021/22/c8250.html </a> </p>
</div>
</div>
<p>News Provided by Canada Newswire via QuoteMedia</p>
<p></p><div class="stock-information sidebar-block">
<div class="title">Request an Investor Kit: <h3>HempFusion Wellness</h3></div>
<form action="https://investingnews.com" id="subscribe_per_category" method="POST">
<div class="form-column left">
<input name="profiles_only" type="hidden" value="yes"/><input name="subscription_form" type="hidden" value="yes"/><input name="subscribe_company_profile_form" type="hidden" value="1"/><input name="source" type="hidden" value="https://investingnews.com/news/biotech-investing/hempfusion-virtually-opens-the-market/"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="form_name" type="hidden" value="subscribe_cprofile_use_posts"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="cprofiles[]" type="hidden" value="Tzo4OiJzdGRDbGFzcyI6NDp7czoyOiJpZCI7czozNjoiMWIyNjFjMDUtNTc0My01MzkxLWE5ZTgtNWZiNmZhZWIwZTEzIjtzOjQ6Im5hbWUiO3M6MTk6IkhlbXBGdXNpb24gV2VsbG5lc3MiO3M6NDoid3BpZCI7czo5OiIxMDE2MTA2OTIiO3M6MzoidXJsIjtzOjA6IiI7fQ=="/><input class="form-control" id="FirstName" name="first_name" placeholder="First Name" required="" type="text" value=""/><input class="form-control" id="LastName" name="last_name" placeholder="Last Name" required="" type="text" value=""/><input class="form-control" id="email" name="email" placeholder="Email" required="" type="email" value=""/><input class="form-control" id="phone" name="user_phone" pattern="[\+\s0-9]{3,15}" placeholder="Phone" title="Telephone number. Only digits and space signs are allowed" type="tel" value=""/></div>
<input class="g-recaptcha-response" id="g-recaptcha-response_3410" name="g-recaptcha-response" type="hidden"/><input class="value_recaptcha" name="action" type="hidden" value="validate_captcha_3410"/><div class="form-column right">
<div class="extra-input">
<input id="AccreditedInvestor" name="accredited_investor" type="checkbox"/><label class="checkbox-label" for="AccreditedInvestor">
Include me in the <b>Accredited Investor</b> email list
<span class="help">
<i aria-hidden="true" class="fa fa-question-circle"></i>
<div class="help-box bigger">
Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above.
</div>
</span>
</label>
</div>
<div class="more">
<input class="btn btn-primary" type="submit" value="Get More information"/></div>
<p class="legend">By completing this form, you are giving consent to receive communication from HempFusion Wellness using the contact information you provide. And remember you can unsubscribe at any time.</p>
</div>
</form>
</div>
Keep reading...
Show less
Revive Therapeutics Included in First Psychedelic Exchange Traded Fund
January 22 | 2021
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.
The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.
<p> “We are pleased to be included in the First Psychedelics ETF and being recognized as a leading company in the field of psychedelic pharmaceuticals,” said Michael Frank, CEO of Revive. “We are advancing novel psilocybin-based therapeutics using a proprietary oral thin film delivery technology and a natural biosynthesis enzymatic platform to support clinical research in mental health and substance abuse disorders.” </p>
<p> Revive is advancing its psychedelic pharmaceuticals pipeline with a focus on proprietary psilocybin-based therapeutics that includes the development of an oral thin film product in collaboration with the University of Wisconsin-Madison, a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform developed by Dr. Gavin Williams, Professor and Researcher at North Carolina State University, a clinical study with the University of Wisconsin evaluating psilocybin in the treatment of methamphetamine use disorder, and the research with psilocybin being developed by PharmaTher Inc. (CSE: PHRM, OTCQB: PHRRF). </p>
<p align="justify"> <strong> About <a href="https://investingnews.com/company-profiles/revive-therapeutics-cse:rvv/">Revive Therapeutics</a> Ltd. </strong> </p>
<p align="justify"> Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the company was granted FDA orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation. For more information, visit <strong> <u> <a href="https://investingnews.com/company-profiles/revive-therapeutics-cse:rvv/" rel="nofollow noopener noreferrer" target="_blank"> www.ReviveThera.com </a> </u> </strong> . </p>
<p> For more information, please contact: </p>
<p> Michael Frank <br/> Chief Executive Officer <br/><a href="https://investingnews.com/company-profiles/revive-therapeutics-cse:rvv/">Revive Therapeutics</a> Ltd. <br/> Tel: 1 888 901 0036 <br/> Email: <a href="https://www.globenewswire.com/Tracker?data=EtV52d11Y90VV2wxfrIC3MyDRJg22HoxbfLz_dyVrWnvVH5zTVtzz2fmjCL7lBFDXfRuxsGMIHUYK_ESYljmuSRlqBds4yREgRDKPsp6yjt4qFMMnaqplXJBDRUIWMefvrFyHUOdiHGU6cew9y1rT-kOlamt0cihKoLwrQrzZVYwN4EYcH56d412SyC-wzVPga6I0mLDFKMdNVglADnUAKi7fBIszJJfAioUdDBAMe_GkE1cz4slukNxD5iPPamaDv9y8AmR8CNZ98M1jhtSeg==" rel="nofollow noopener noreferrer" target="_blank"> <u> mfrank@revivethera.com </u> </a> <br/> Website: <u> <a href="https://investingnews.com/company-profiles/revive-therapeutics-cse:rvv/" rel="nofollow noopener noreferrer" target="_blank"> www.revivethera.com </a> </u> </p>
<p align="justify"> <em> Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of this release. </em> </p>
<p align="justify"> <em> Cautionary Statement </em> </p>
<p align="justify"> <em> This press release contains ‘forward-looking information’ within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on Revive’s current belief or assumptions as to the outcome and timing of such future events. Forward looking information in this press release includes information with respect to the Offering, including the intended use of proceeds. Forward-looking information is based on reasonable assumptions that have been made by Revive at the date of the information and is subject to known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in the forward-looking information. Given these risks, uncertainties and assumptions, you should not unduly rely on these forward-looking statements. The forward-looking information contained in this press release is made as of the date hereof, and Revive is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. The foregoing statements expressly qualify any forward-looking information contained herein. Reference is made to the risk factors disclosed under the heading “Risk Factors” in the Company’s annual MD&A for the fiscal year ended June 30, 2020, which has been filed on SEDAR and is available under the Company’s profile at </em> <em> <u> <a href="https://www.globenewswire.com/Tracker?data=d5NuHT5oADXkgdbfR7C54nWzMKCOOMPZhwq1ueu3QRmyN9Bu1nuphd1fps4l_NIhyruBZfXaldgtxU3gMhSVUw==" rel="nofollow noopener noreferrer" target="_blank"> www.sedar.com </a> </u> </em> <em> . </em> </p>
<p> <img class="lazy" data-src="https://www.globenewswire.com/newsroom/ti?nf=ODE0MDIxNyMzOTQxMDEzIzIwOTM4Nzc=" data-srcset="" height="1" src="https://www.globenewswire.com/newsroom/ti?nf=ODE0MDIxNyMzOTQxMDEzIzIwOTM4Nzc=" srcset="" width="1"/><br/><img class="lazy" data-src="https://ml.globenewswire.com/release/track/9e229062-3dc1-4890-adf0-12f64a265b2f" data-srcset="" height="1" referrerpolicy="no-referrer-when-downgrade" src="https://ml.globenewswire.com/release/track/9e229062-3dc1-4890-adf0-12f64a265b2f" srcset="" width="1"/></p>
<p> <a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/495ebaf7-944d-442b-bb09-8e0c4ccdb88a" rel="noopener noreferrer" target="_blank"> <img alt="Primary Logo" border="0" class="lazy" data-src="https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png" data-srcset="" height="44" src="https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png" srcset="" width="150"/></a> </p>
</div>
<p>News Provided by GlobeNewswire via QuoteMedia</p>
<p></p><div class="stock-information sidebar-block">
<div class="title">Request an Investor Kit: <h3>Revive Therapeutics</h3></div>
<form action="https://investingnews.com" id="subscribe_per_category" method="POST">
<div class="form-column left">
<input name="profiles_only" type="hidden" value="yes"/><input name="subscription_form" type="hidden" value="yes"/><input name="subscribe_company_profile_form" type="hidden" value="1"/><input name="source" type="hidden" value="https://investingnews.com/news/biotech-investing/revive-therapeutics-included-in-first-psychedelic-exchange-traded-fund/"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="form_name" type="hidden" value="subscribe_cprofile_use_posts"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="cprofiles[]" type="hidden" value="Tzo4OiJzdGRDbGFzcyI6NDp7czoyOiJpZCI7czozNjoiOGIyNDU4MDctOGIwYS0zNDNlLTU4ZDItNWU5NWY1ZmMyMTNmIjtzOjQ6Im5hbWUiO3M6MTk6IlJldml2ZSBUaGVyYXBldXRpY3MiO3M6NDoid3BpZCI7czo5OiIxMDE1NjQzMjUiO3M6MzoidXJsIjtzOjA6IiI7fQ=="/><input class="form-control" id="FirstName" name="first_name" placeholder="First Name" required="" type="text" value=""/><input class="form-control" id="LastName" name="last_name" placeholder="Last Name" required="" type="text" value=""/><input class="form-control" id="email" name="email" placeholder="Email" required="" type="email" value=""/><input class="form-control" id="phone" name="user_phone" pattern="[\+\s0-9]{3,15}" placeholder="Phone" title="Telephone number. Only digits and space signs are allowed" type="tel" value=""/></div>
<input class="g-recaptcha-response" id="g-recaptcha-response_9657" name="g-recaptcha-response" type="hidden"/><input class="value_recaptcha" name="action" type="hidden" value="validate_captcha_9657"/><div class="form-column right">
<div class="extra-input">
<input id="AccreditedInvestor" name="accredited_investor" type="checkbox"/><label class="checkbox-label" for="AccreditedInvestor">
Include me in the <b>Accredited Investor</b> email list
<span class="help">
<i aria-hidden="true" class="fa fa-question-circle"></i>
<div class="help-box bigger">
Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above.
</div>
</span>
</label>
</div>
<div class="more">
<input class="btn btn-primary" type="submit" value="Get More information"/></div>
<p class="legend">By completing this form, you are giving consent to receive communication from Revive Therapeutics using the contact information you provide. And remember you can unsubscribe at any time.</p>
</div>
</form>
</div>
Keep reading...
Show less